Trials / Completed
CompletedNCT00426179
Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen
An Exploratory Study of the Effects of Imatinib on Allergic Inflammation Following Out of Allergy Season Repeated Nasal Allergen Challenge in Subjects With Seasonal Allergic Rhinitis Sensitive to Timothy Grass Pollen - an Exploratory Study of c-Kit Inhibition in Allergic Respiratory Diseases
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the effects of Imatinib on allergic inflammation following repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imatinib |
Timeline
- Start date
- 2006-12-01
- Completion
- 2007-08-01
- First posted
- 2007-01-24
- Last updated
- 2007-11-19
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00426179. Inclusion in this directory is not an endorsement.